Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan extension study in children with hypertension
2006-005408-14Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of valsartan and enalapril in hypertension (HTN) (3 arms), sponsored by Novartis. Primary endpoint: Long-term safety and tolerability. Started Feb 2007; status: completed.
02
Drugs
valsartanenalapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-005408-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005408-14.